Across TCGA pan-cancer cohorts, ZNF736P7Y RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of ZNF736P7Y’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF736P7Y RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF736P7Y is over-expressed in tumor.
KIRC are the cancer types where ZNF736P7Y tumor–normal differential expression is most reproducible.